Replies to post #168566 on Anavex Life Sciences Corp (AVXL)

[bas2020]

There is always more interest in biotechs that are well into P3 than those that aren't. AVXL's time will come... sooner than expected from a clinical trial development viewpoint.

[XenaLives]

Vtvt is closely held, may be a P&D...

https://endpts.com/little-vtv-therapeutics-adds-another-round-of-bad-data-on-alzheimers-drug-but-they-still-love-their-chances/

https://ih.advfn.com/p.php?pid=nmona&article=78375449

http://www.macandrewsandforbes.com/portfolio/

[Bourbon_on_my_cornflakes]

"Here is the news for VTVT and the presentation in Barcelona.

https://seekingalpha.com/news/3397884-vtv-therapeutics-leaps-49-percent-sets-alzheimers-presentation

AVXL has no such response."

VTVT already down 10% today with a market cap 1/3 of AVXL's